BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22743209)

  • 1. Treatment of diastolic dysfunction in hypertension.
    Ginelli P; Bella JN
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):613-8. PubMed ID: 22743209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of diastolic heart failure.
    Kazik A; Wilczek K; Poloński L
    Cardiol J; 2010; 17(6):558-65. PubMed ID: 21154257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K; Palmieri V; Gerdts E; Bella JN; Aurigemma GP; Papademetriou V; Dahlöf B; Aalto T; Ibsen H; Rokkedal JE; Devereux RB
    Am J Cardiol; 2010 Oct; 106(7):999-1005. PubMed ID: 20854964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and cardiac failure in its various forms.
    Gaddam KK; Verma A; Thompson M; Amin R; Ventura H
    Med Clin North Am; 2009 May; 93(3):665-80. PubMed ID: 19427498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of diastolic dysfunction and heart failure.
    Satpathy C; Mishra TK; Satpathy R; Satpathy HK; Barone E
    Am Fam Physician; 2006 Mar; 73(5):841-6. PubMed ID: 16529092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.
    Shinde AA; Anderson AS
    Heart Fail Clin; 2008 Oct; 4(4):479-503. PubMed ID: 18760759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Left ventricular diastolic function and dysfunction: a single cardiac target for various systemic diseases].
    Caserta MA; Milan A; Naso D; Magnino C; Puglisi E; Saglio E; Monticone S; Veglio F
    G Ital Cardiol (Rome); 2007 May; 8(5):279-98. PubMed ID: 17650687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.
    Teupe C; Rosak C
    Diabetes Res Clin Pract; 2012 Aug; 97(2):185-94. PubMed ID: 22502812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy for diastolic heart failure].
    Anguita Sánchez M; Ojeda Pineda S
    Rev Esp Cardiol; 2004 Jun; 57(6):570-5. PubMed ID: 15225503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.
    Betocchi S; Chiariello M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S116-21. PubMed ID: 1381787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.